Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety, side effects, and dosage for
Motexafin Gadolinium given with the chemotherapy drug docetaxel to patients with advanced
cancers. Secondly, tumor response to the combined treatment, drug levels in the body, and
drug interactions will be evaluated.